30.07.2013 • NewsBASFClariantQ2 2013

Clariant Profit Rises as Restructuring Bears Fruit

Swiss speciality chemicals maker Clariant posted a better than expected second-quarter profit as it reaped gains from a restructuring and said it was slowly moving towards its short and mid-term targets.

Net profit rose to 79 million Swiss francs ($84.8 million) from 68 million francs a year earlier on the back of 1.54 billion in revenues, up 2% in local currencies.

Analysts on average had forecast net profit of 68.3 million francs and sales of 1.55 billion francs in a Reuters poll.

The company sold three of its lower margin cyclical units late last year and reorganized itself into four business units - care chemicals, plastics and coatings, natural resources and catalysis and energy.

Chief Executive Hariolf Kottmann said the shine was coming off emerging markets, but that the company continued to see a fairly stable economic environment, albeit at a low level.

Last week, Germany's BASF called its 2013 profit goal into question as shrinking European markets and slower growth in China weighed on its second-quarter profit.

Clariant confirmed its 2015 guidance for a pretax core profit margin before exceptional items of above 17% and a return on invested capital above the peer group average.

Last month, Clariant said products currently under development could net sales of over 1 billion Swiss francs by 2017.

 

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.